Sit Investment Associates’s AbbVie ABBV Stock Holding History

Sit Investment Associates’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$9.83M	Sell	45,194 -21,102	-32%	-$4.68M	0.2%	132
2025 Q4	$15.1M	Sell	66,296 -5,113	-7%	-$1.16M	0.3%	80
2025 Q3	$16.5M	Sell	71,409 -8,359	-10%	-$1.7M	0.34%	70
2025 Q2	$14.8M	Buy	79,768 +773	+1%	+$144K	0.32%	79
2025 Q1	$16.6M	Sell	78,995 -11,233	-12%	-$2.18M	0.39%	72
2024 Q4	$16M	Buy	90,228 +7,771	+9%	+$1.43M	0.36%	71
2024 Q3	$16.3M	Sell	82,457 -6,920	-8%	-$1.29M	0.36%	77
2024 Q2	$15.3M	Buy	89,377 +33,847	+61%	+$5.61M	0.35%	80
2024 Q1	$10.1M	Buy	55,530 +24,205	+77%	+$4.17M	0.23%	126
2023 Q4	$4.85M	Buy	+31,325	New	+$4.57M	0.12%	210
2022 Q3	–	Sell	-45,509	Closed	-$6.97M	–	519
2022 Q2	$6.97M	Sell	45,509 -77,425	-63%	-$11.8M	0.21%	135
2022 Q1	$19.9M	Sell	122,934 -32,366	-21%	-$4.7M	0.54%	49
2021 Q4	$21M	Sell	155,300 -7,915	-5%	-$935K	0.49%	57
2021 Q3	$17.6M	Sell	163,215 -23,440	-13%	-$2.68M	0.46%	60
2021 Q2	$21M	Buy	186,655 +7,637	+4%	+$860K	0.52%	53
2021 Q1	$19.4M	Buy	179,018 +11,580	+7%	+$1.24M	0.51%	52
2020 Q4	$17.9M	Buy	167,438 +2,158	+1%	+$207K	0.49%	55
2020 Q3	$14.5M	Buy	165,280 +65,970	+66%	+$6.21M	0.43%	65
2020 Q2	$9.75M	Buy	99,310 +93,265	+1,543%	+$8.21M	0.31%	104
2020 Q1	$461K	Hold	6,045	–	–	0.02%	375
2019 Q4	$535K	Sell	6,045 -3,500	-37%	-$291K	0.02%	382
2019 Q3	$723K	Sell	9,545 -61,220	-87%	-$4.2M	0.02%	358
2019 Q2	$5.15M	Sell	70,765 -112,525	-61%	-$8.84M	0.16%	168
2019 Q1	$14.8M	Sell	183,290 -107,200	-37%	-$8.77M	0.47%	59
2018 Q4	$26.8M	Sell	290,490 -118,010	-29%	-$10.4M	0.86%	24
2018 Q3	$38.6M	Sell	408,500 -880	-0.2%	-$83.5K	0.99%	17
2018 Q2	$37.9M	Sell	409,380 -14,710	-3%	-$1.44M	0.98%	19
2018 Q1	$40.1M	Sell	424,090 -2,600	-0.6%	-$286K	0.99%	18
2017 Q4	$41.3M	Sell	426,690 -4,745	-1%	-$447K	0.98%	19
2017 Q3	$38.3M	Sell	431,435 -99,095	-19%	-$7.54M	0.95%	19
2017 Q2	$38.5M	Sell	530,530 -46,670	-8%	-$3.14M	0.95%	17
2017 Q1	$37.6M	Buy	577,200 +110,380	+24%	+$6.94M	0.94%	22
2016 Q4	$29.2M	Sell	466,820 -23,625	-5%	-$1.44M	0.77%	31
2016 Q3	$30.9M	Sell	490,445 -15,050	-3%	-$974K	0.82%	27
2016 Q2	$31.3M	Sell	505,495 -371,050	-42%	-$22.6M	0.83%	26
2016 Q1	$50.1M	Sell	876,545 -118,305	-12%	-$6.59M	0.92%	29
2015 Q4	$58.9M	Sell	994,850 -133,970	-12%	-$7.72M	1.1%	20
2015 Q3	$61.4M	Buy	1,128,820 +279,350	+33%	+$18.2M	1.15%	16
2015 Q2	$57.1M	Sell	849,470 -39,321	-4%	-$2.57M	1.05%	21
2015 Q1	$52M	Buy	+888,791	New	+$53.7M	0.9%	26
2014 Q3	–	Sell	-17,930	Closed	-$1.01M	–	430
2014 Q2	$1.01M	Hold	17,930	–	–	0.02%	335
2014 Q1	$922K	Hold	17,930	–	–	0.02%	353
2013 Q4	$947K	Hold	17,930	–	–	0.02%	356
2013 Q3	$802K	Hold	17,930	–	–	0.02%	351
2013 Q2	$741K	Buy	+17,930	New	+$784K	0.02%	346

Other funds holding ABBV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Sit Investment Associates's ABBV Position: Q1 2026 in Review

Sit Investment Associates reduced its AbbVie (ABBV) stake by 32% in Q1 2026, selling an estimated $4.68M and leaving 45,194 shares worth $9.83M. The position accounts for 0.2% of the portfolio, ranked #132.

Sit Investment Associates first reported a position in ABBV in Q2 2013 and has held it in 45 quarters since. The position peaked at $61.4M in Q3 2015. 4,080 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

Sit Investment Associates held 45,194 shares of AbbVie worth $9.83M as of Q1 2026.
Sit Investment Associates sold 21,102 AbbVie shares in Q1 2026, an estimated $4.68M.
AbbVie made up 0.2% of Sit Investment Associates's portfolio in Q1 2026, its #132 holding.
Sit Investment Associates first reported a position in AbbVie in Q2 2013 and has held it in 45 quarters since.
Sit Investment Associates's AbbVie position peaked at $61.4M in Q3 2015.
4,080 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Sit Investment Associates's 13F filing for Q1 2026, filed 13 May 2026.